Market Overview:
The global empty capsules market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 3.1 Billion |
Market Forecast in 2032
|
US$ 5.5 Billion |
Market Growth Rate (2024-2032) |
6.6% |
Empty capsules refer to a stable shell encapsulating medicines that are administered in the patient’s body in various dosage forms, such as granules and pellets. They are commercially available in two varying types, gelatin and non-gelatin. The gelatin capsules (hard and soft) are a high collagen animal-based medicine manufactured from pig meat and beef and chicken connective tissues. On the other hand, the non-gelatin, or vegetarian capsule, is produced from the blend of starch and hydroxypropyl methylcellulose (HPMC). Currently, empty capsules find extensive applications in healthcare and therapeutic applications.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Empty Capsules Market Trends:
The increasing prevalence of cardiovascular and chronic diseases and the rising geriatric population are some of the key factors driving the empty capsule market growth. In line with this, the introduction of capsule-in-capsule technology to ensure gastrointestinal safety of those patients that did not receive capsule medication is another growth-inducing factor. Moreover, the rising demand for the immediate-release capsule by manufacturers for producing various medicinal products, such as antibacterial, antiacids, inhalers, dietary supplements, painkillers, and antibiotics, are contributing to the market growth. The rapid expansion in the healthcare industry and the widespread adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC) due to its moderate strength, transparency, and resistance to oil and fat properties, are propelling the market growth. Additionally, the increasing investments in the research and development (R&D) activities in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs is positively stimulating the market growth. Other factors, such as the easy access to advanced treatment options, strategic collaborations between the empty capsule suppliers and gelatin manufacturers, and the growing demand for various dietary supplements, immunity boosters, and drugs, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global empty capsules market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, raw material, functionality, therapeutic application, and end user.
Breakup by Type:
- Gelatin Capsule
- Non-gelatin Capsule
Breakup by Raw Material:
- Pig Meat
- Bovine Meat
- Bone
- Hydroxypropyl Methylcellulose (HPMC)
- Others
Breakup by Functionality:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Immediate-release Capsules
- Sustained-release Capsules
- Delayed-release Capsules
Breakup by Therapeutic Application:
- Antibiotic and Antibacterial Drugs
- Vitamins and Dietary Supplements
- Antacid and Antiflatulent Preparations
- Cardiovascular Therapy Drugs
- Others
Breakup by End User:
- Pharmaceutical Industry
- Nutraceutical Industry
- Cosmetics Industry
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Type, Raw Material, Functionality, Therapeutic Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |